NYSE · Key Statistics

vVARDIS HOLDING AG Class A (VVVV) P/E Ratio, ROE & Key Statistics

$16.02 NYSE: VVVV Market Cap $328.60M

Data as of Nov 16, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for vVARDIS HOLDING AG Class A (VVVV), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

MetricValue
P/S ratioMarket value divided by annual revenue.60.15

Profitability

MetricValue
Gross marginRevenue left after the direct cost of goods sold.85.39%
Operating marginRevenue left after operating costs.-68.89%
Net marginRevenue left after every cost, including tax and interest.-105.16%

Financial health

MetricValue
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.0.96

Per share and size

MetricValue
Market capitalisationShare price times shares outstanding.$328.60M

vVARDIS HOLDING AG Class A (VVVV) statistics — frequently asked questions

How much debt does vVARDIS HOLDING AG Class A carry?

vVARDIS HOLDING AG Class A (VVVV) has a debt-to-equity ratio of 0.00, which compares total borrowings with shareholders' equity.

What is vVARDIS HOLDING AG Class A's profit margin?

vVARDIS HOLDING AG Class A (VVVV) keeps -105.16% of revenue as net profit after every cost, including tax and interest.

P/E and ROE of other Medical - Specialties stocks

ALC P/E 54.50STE P/E 30.38MLAB P/E 116.10QDEL ROE -20.13%MOBI key statisticsSI ROE -25.67%MASS ROE -17.42%ANIK ROE -1.28%APYX ROE -70.78%SKIN ROE -32.09%All Healthcare stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.